News

The agreement resolves litigation that was pending in the US District Court of Texas with respect to certain Ethicon products. Ethicon is a subsidiary of Johnson & Johnson.

Mr Walker was most recently the chairman and CEO of Novacea, which merged with Transcept Pharmaceuticals in January 2009. Mr Walker currently serves on the board of directors

These positions were eliminated after Panacos sold bevirimat, and the company has refocused its efforts on its early stage programs. Dr McCallister has served in this capacity since

According to the company, results of initial studies outline the device’s ability to significantly improve drug delivery to mucous membranes such as those in the nose, intestine, eyes,

Mr Fincher’s primary areas of focus will be the medical markets in Mexico, Brazil, Argentina and Chile, although he will also work with all of the Latin American

Palatin has also earned a milestone payment of $2.5 million in connection with its collaboration and licensing agreement with AstraZeneca. Palatin anticipates receiving the $2.5 million in the

Most recently, Mr Shrewsbury served as chief medical officer and senior vice president of clinical development and regulatory affairs at Adamas Pharmaceuticals. Prior to that, Mr Shrewsbury served

Based on the outcome of the study, Guided Therapeutics (GT) plans to submit the trial results to the FDA as part of the premarket approval (PMA) application for

The Phase I clinical trial is designed to assess the safety, tolerability and pharmacokinetics of IB1001 in patients with hemophilia B, compared with the commercially available recombinant Factor